FT Digital Health Summit Europe 2017

Start:
Tue, 27 Jun 2017, 08:00
End:
Tue, 27 Jun 2017, 05:40
Hashtag:
#FTDigHealth
Venue:
Symposia
Workshops
Organiser
Sponsor
WHY ATTEND?
- Assess how patients are being empowered and further involved in the transformation of healthcare
- Hear how collaborations between pharma and big tech are enriching the commercial viability of digital health
- Meet and greet with the full array of industry stakeholders, from healthcare to technology, pharma to start-ups, regulation to government
- Identify solutions in overcoming cyber security threats in digital health
- Don’t get left behind - be part of a must-attend event mapping the continued transformation of healthcare
WHO ATTENDS?
FT Live has a reputation for delivering very senior board level audiences to attend a wide range of world class thought-leadership events across the globe for nearly 40 years.
The FT Digital Health Summit Europe will be attended by:
- Life science companies
- Pharmaceutical and biotechnology companies
- Healthcare providers
- Multi-technology corporations
- Investment banks
- Medical device manufacturers
- Health insurers
- Health/big data companies
- Venture capitalists
- Health regulatory agencies
- Mobile app providers
- Mobile operators and service providers
- Technology consultancies
- Management consultancies
- Telemedicine companies
- Mobile technology manufacturers
- Digital health companies
- Data integrators/analytics/brokers
- Genomics/personalised medicine related companies
- Wireless-device manufacturers
If you book before Thursday 6th April, you will be entitled to a further reduction of £100.
FEES
Ticket Type | Fee |
Early Bird Ticket (ends 6 April) | £799 +VAT |
Standard Summit Ticket | £899 +VAT |
AGENDA - 27TH JUN | |
8:00am | Registration and welcome reception |
9:00am | Opening remarks from the Chair |
David Crow, Senior US Business Correspondent, Financial Times | |
9:05am | Panel keynote: Accepting digital health - how much do patients want it? |
Juliet Bauer, Director of Digital Experience, NHS England | |
9:15am | Accepting digital health: How much do patients want it? |
What is the likelihood of providing a digital healthcare system that enables patients of all demographics to use it? | |
What are the challenges for integrating technology from different providers into one healthcare experience for the patient? | |
What can be done to increase the use of telemedicine services? | |
A view from the clinic - are GP telemedicine consultations working? | |
Juliet Bauer, Director of Digital Experience, NHS England | |
Chris Day, Director of Engagement, Care Quality Commission | |
Rachel Dunscombe, Chief Information Officer, Salford Royal NHS Foundation Trust | |
Robert Johnstone, Patient Advocate and Board Member, European Patients Forum | |
9:55am | NHS Digital Keynote |
Beverley Bryant, Director of Digital Transformation, NHS Digital | |
10:20am | Doctors and Machines: The growing role of advanced technologies in healthcare |
What are the main barriers to overcome when trying to move AI in healthcare from the R&D lab to the surgery? | |
Will advanced machines create even more uncertainty and worry around access to private medical records? | |
How could technology alter the reimbursement models for healthcare? | |
Is AI one step too far when asking patients to trust technology in an industry dominated by human interactions? | |
Adam Hanina, CEO, AiCure | |
Professor Andrew Price, Professor of Orthopaedic Surgery, University of Oxford | |
10:50am | Morning break |
11:20am | Policy Keynote |
11:50am | Investing in tech-enabled health now and for a post-Brexit future |
Like other markets before it, will digital health investments inevitably reach their peak and slump? | |
Exploring EU sources of funding: What will happen to them post-Brexit? | |
Can companies entice investors to come on board with longer term views in mind? | |
How have the exit strategies changed and are they altering the investor mix? | |
What would an opening to public markets do for the digital health industry? | |
What models are showing the best capital returns? | |
Dr Vishal Gulati, Healthtech Venture Capitalist, Draper Esprit | |
12:30pm | The economic view - how to monetise the next phase of healthcare's transformation |
Which key consumer and patient behavioural patterns are changing the economic landscape for healthcare | |
Defining the value of digital health by patient activation levels and how, if improved, can they significantly reduce healthcare costs? | |
Will an economic health model driven more by consumers and patients rather than providers cause significant regulatory problems? | |
What happens when your innovation is too innovative and worries investors? Is this economically sustainable? | |
How can NHS England create a single market entry point for new products and services, much like its partners in Scotland and Wales? | |
Clara Leonard, Associate, Digital Health Ventures | |
1:10pm | Lunch |
2:15pm | Case study: Healthcare Heroes |
Matt Eagles, Patient | |
David Hunt, Chief Executive, HAVAS LYNX | |
2:30pm | Spotlight session |
2:30pm | Disruptor 1 - Dr Talya Miron-Shatz, CEO, CureMyWay and Co-founder, Buddy&Soul |
2:45pm | Disruptor 2 - Dr Sukhbinder Noorpuri, Founder and CEO, i-GP |
3:00pm | Disruptor 3 - Dr Sai Lakshmi, CEO and Co-founder, Echo |
3:15pm | Digital health as a driving force for improving medical adherence |
When will mHealth become the norm for tracking patient adherence? | |
How can digital health technologies be used to improve adherence in clinical trials? | |
Dr Ralph Abraham, Founder, London Medical | |
Dr Junaid Bajwa, Executive Director for Healthcare Services, MSD | |
Mark Duman, Non-Executive Director, Patient Information Forum | |
3:55pm | Afternoon break |
4:15pm | The new look for providers - collaborating with a transforming industry |
What are the key areas that providers are exploring in the digital health space? | |
What is joint working in digital health and what evidence is there of this being successful on a mainstream basis? | |
Who are the partners they most need and are most keen on partnering with? | |
What role can healthcare partnerships play in making clinical trials more efficient? | |
How can providers and pharma companies harness data and feedback to better develop products and services in partnership with the NHS? | |
Dr Sameer Mistry, Medical Director, UK and Ireland, Johnson & Johnson Medical Devices | |
Irina Osovskaya, Global Director of Mobile and Customer Experience Strategy, AstraZeneca | |
4:55pm | Plug and play healthcare: An ecosystem accessible for all demographics |
How can we overcome a lack of Chief Information and Innovation Officers, who can really drive forward a digital health agenda? | |
What type of partners are healthcare organisations looking for in order to improve their interoperability? | |
What impact will the creation of digital academies have? | |
Analysing the outcomes from the NHS’s Wachter Review | |
Julie Bretland, Director, Our Mobile Health | |
Charles Lowe, Managing Director, Digital Health and Care Alliance / Past President - Telemedicine Section, Royal Society of Medicine | |
5:35pm | Closing remarks from the Chair |
5:40pm | Drinks reception |
Juliet Bauer Director of Digital Experience NHS England | |
Beverley Bryant Director of Digital Transformation NHS Digital | |
Rachel Dunscombe Chief Information Officer Salford Royal NHS Foundation Trust | |
Julie Bretland Director Our Mobile Health | |
Dr Karl Pall Director of Brand Solutions DACH (Germany, Austria and Switzerland) |
More events

Mon, 28 Apr 2025 - Wed, 30 Apr 2025

Sat, 3 May 2025 - Tue, 6 May 2025

Mon, 19 May 2025 - Wed, 21 May 2025

Sun, 1 Jun 2025 - Tue, 3 Jun 2025


Sat, 9 Aug 2025 - Wed, 13 Aug 2025

Wed, 8 Oct 2025 - Fri, 10 Oct 2025

Tue, 21 Oct 2025 - Wed, 22 Oct 2025

Mon, 24 Nov 2025 - Tue, 25 Nov 2025

Wed, 28 Jan 2026 - Thu, 29 Jan 2026